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Introduction: Photoacoustic (PA) imaging is a hybrid modality, combining the high sensitivity 
of optical imaging and the high resolution of acoustic imaging, and thus offers a unique 
opportunity to improve the early detection of cancer cells. This work aims to develop a silica 
coated iron oxide (SIO) nanoparticle as a potent cancer cell selective PA contrast agent, with a 
high binding affinity and selectivity to the gastrin releasing peptide receptor (GRPR) which is 
overexpressed in many human cancers including prostate cancer, breast cancer and small cell 
lung cancer etc.  
 
Methods: Silica coated iron oxide (IO) nanoparticle was synthesized and conjugated with 
bombesin (BBN) peptide and AlexaFluor750 (AF750) dye to form SIO-AF750-BBN. This 
hybrid nanoparticle was purified and characterized by Transmission Electron Microscopy (TEM), 
Fourier Transform Infrared Spectroscopy (FTIR), Atomic Force Microscopy (AFM) and 
electrochemistry. In vitro binding affinity was determined by a competitive IC50 assay against 
the gold standard 125I-Tyr4-BBN for GRPR on human prostate cancer PC-3 cells. In vivo 
evaluation was performed in mice bearing PC-3 tumors to explore the in vivo binding affinity 
and specificity, as well as the PA imaging efficacy, pharmacokinetics, and biodistribution of the 
SIO-AF750-BBN nanoparticle.  
 
Results and Discussion: SIO-AF750-BBN has a core diameter of 9.7±0.7 nm and a silica 
coating thickness of 7.5±0.9 nm, and 4.6 AF750-BBN per nanoparticle. The photoacoustic signal 
strength of SIO-BBN-AF750 was examined and compared to SIO, IO, and AF750-BBN in near 
infrared (NIR) wavelength range of 680-970 nm. SIO-AF750-BBN showed the strongest PA 
enhancement with a peak at 740 nm, over the bare SIO or IO nanoparticle or the bare AF750-
BBN molecule. In vitro cell binding experiment showed that SIO-AF750-BBN had a high 
binding specificity and affinity to the GRPRs, with an IC50 = 19.3 ± 3.7 nM for PC-3 cells. In 
vivo NIRF imaging of SIO-AF750-BBN was performed in prostate cancer PC-3 tumor bearing 
mice 1-hour after tail vein injection, and showed a significantly higher intensity in tumor tissues 
in the uptake group than that of the receptor-blocking group, indicating a high in vivo binding 
specificity and sensitivity of SIO-AF750-BBN to GRPRs on PC-3 tumors. In vivo photoacoustic 
images were performed at 680-970 nm wavelength range pre- and 1-hour post-tail vein injections. 
The SIO-AF750-BBN uptake group showed the most photoacoustic signal enhancement 
especially in the tumor core, while the receptor-blocking group and the small molecule AF750-
BBN group showed significantly lower PA signals (approximately 35% and 22% that of the SIO-
AF750-BBN group, respectively, at 750 nm). The result shows the high in vivo photoacoustic 
sensitivity of SIO-AF750-BBN on the PC-3 tumors.  
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Conclusion: SIO-AF750-BBN is a promising nanoparticle for site-specific targeting and 
photoacoustic imaging of cancer cells expressing gastrin releasing peptide receptors such as 
prostate cancer.  
